Mercer Global Advisors Inc. ADV grew its position in shares of Envista Holdings Co. (NYSE:NVST – Free Report) by 13.8% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,753 shares of the company’s stock after purchasing an additional 1,670 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Envista were worth $229,000 as of its most recent SEC filing.
Other hedge funds have also modified their holdings of the company. Versant Capital Management Inc grew its holdings in shares of Envista by 1,420.3% during the second quarter. Versant Capital Management Inc now owns 3,147 shares of the company’s stock worth $52,000 after purchasing an additional 2,940 shares during the last quarter. Innealta Capital LLC acquired a new stake in shares of Envista during the 2nd quarter valued at approximately $78,000. Summit Securities Group LLC acquired a new stake in shares of Envista during the 2nd quarter valued at approximately $85,000. Signaturefd LLC lifted its position in shares of Envista by 85.9% during the 2nd quarter. Signaturefd LLC now owns 5,345 shares of the company’s stock valued at $89,000 after acquiring an additional 2,470 shares during the period. Finally, TFO Wealth Partners LLC raised its position in shares of Envista by 64,777.8% during the 4th quarter. TFO Wealth Partners LLC now owns 5,839 shares of the company’s stock worth $140,000 after purchasing an additional 5,830 shares during the last quarter.
Insiders Place Their Bets
In other news, CFO Eric D. Hammes bought 24,532 shares of the firm’s stock in a transaction on Monday, August 12th. The stock was purchased at an average price of $16.33 per share, for a total transaction of $400,607.56. Following the transaction, the chief financial officer now owns 24,532 shares in the company, valued at $400,607.56. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 1.30% of the stock is owned by insiders.
Envista Price Performance
Envista (NYSE:NVST – Get Free Report) last announced its quarterly earnings data on Wednesday, August 7th. The company reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.27 by ($0.16). Envista had a negative net margin of 52.25% and a positive return on equity of 4.86%. The business had revenue of $633.10 million for the quarter, compared to the consensus estimate of $646.88 million. During the same period in the prior year, the company earned $0.43 EPS. Envista’s quarterly revenue was down 4.4% on a year-over-year basis. On average, sell-side analysts anticipate that Envista Holdings Co. will post 0.69 EPS for the current year.
Analyst Ratings Changes
Several research analysts recently issued reports on the company. Stifel Nicolaus cut their price objective on Envista from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Tuesday, July 30th. JPMorgan Chase & Co. cut shares of Envista from an “overweight” rating to a “neutral” rating and lowered their target price for the stock from $23.00 to $16.00 in a research note on Thursday, August 8th. Needham & Company LLC reaffirmed a “hold” rating on shares of Envista in a research note on Thursday, August 8th. Robert W. Baird lowered their price objective on shares of Envista from $19.00 to $17.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Bank of America lowered their price objective on shares of Envista from $22.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 8th. Three analysts have rated the stock with a sell rating, eight have issued a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $19.59.
View Our Latest Stock Report on NVST
Envista Company Profile
Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.
Further Reading
- Five stocks we like better than Envista
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- TJX Stock: A Buying Opportunity Before the Holiday Rush
- Energy and Oil Stocks Explained
- Micron’s Blowout Results Pave the Way for Seagate’s Stock Surge
- Roth IRA Calculator: Calculate Your Potential Returns
- Zeta Global’s AI Cloud: Your Secret Weapon for Massive Growth
Receive News & Ratings for Envista Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envista and related companies with MarketBeat.com's FREE daily email newsletter.